Upadacitinib for Papuloerythroderma of Ofuji: A 24-Month Outcome.

Perazzolli G, Danese A, Bellini V, Gisondi P

Open source

DOI
10.1111/ijd.70706
Published
2026 Sep 24
Container
International journal of dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ijd.70706,
  title = {Upadacitinib for Papuloerythroderma of Ofuji: A 24-Month Outcome.},
  author = {Perazzolli G and Danese A and Bellini V and Gisondi P},
  year = {2026},
  journal = {International journal of dermatology},
  doi = {10.1111/ijd.70706},
  url = {https://doi.org/10.1111/ijd.70706}
}

RIS

TY  - JOUR
TI  - Upadacitinib for Papuloerythroderma of Ofuji: A 24-Month Outcome.
AU  - Perazzolli G
AU  - Danese A
AU  - Bellini V
AU  - Gisondi P
PY  - 2026
JO  - International journal of dermatology
DO  - 10.1111/ijd.70706
UR  - https://doi.org/10.1111/ijd.70706
ER  - 

APA

G, P., A, D., V, B., & P, G. (2026). Upadacitinib for Papuloerythroderma of Ofuji: A 24-Month Outcome.. International journal of dermatology. https://doi.org/10.1111/ijd.70706

Source records